Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

This study has been completed.
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Chiron Corporation
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute Identifier:
First received: January 6, 2005
Last updated: August 15, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)